Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1979 1
1982 1
1985 1
1989 2
1990 3
1991 1
1997 1
1998 1
1999 2
2001 5
2002 8
2003 7
2004 1
2006 2
2007 2
2008 3
2009 5
2010 3
2011 10
2012 15
2013 7
2014 13
2015 16
2016 15
2017 21
2018 16
2019 29
2020 24
2021 30
2022 23
Text availability
Article attribute
Article type
Publication date

Search Results

232 results
Results by year
Filters applied: . Clear all
Page 1
Mechanisms of nuclear content loading to exosomes.
Yokoi A, Villar-Prados A, Oliphint PA, Zhang J, Song X, De Hoff P, Morey R, Liu J, Roszik J, Clise-Dwyer K, Burks JK, O'Halloran TJ, Laurent LC, Sood AK. Yokoi A, et al. Sci Adv. 2019 Nov 20;5(11):eaax8849. doi: 10.1126/sciadv.aax8849. eCollection 2019 Nov. Sci Adv. 2019. PMID: 31799396 Free PMC article.
E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Yamada K, Hori Y, Inoue S, Yamamoto Y, Iso K, Kamiyama H, Yamaguchi A, Kimura T, Uesugi M, Ito J, Matsuki M, Nakamoto K, Harada H, Yoneda N, Takemura A, Kushida I, Wakayama N, Kubara K, Kato Y, Semba T, Yokoi A, Matsukura M, Odagami T, Iwata M, Tsuruoka A, Uenaka T, Matsui J, Matsushima T, Nomoto K, Kouji H, Owa T, Funahashi Y, Ozawa Y. Yamada K, et al. Among authors: yokoi a. Cancer Res. 2021 Feb 15;81(4):1052-1062. doi: 10.1158/0008-5472.CAN-20-0782. Epub 2021 Jan 6. Cancer Res. 2021. PMID: 33408116
Inhibition of FGFR Reactivates IFNγ Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies.
Adachi Y, Kamiyama H, Ichikawa K, Fukushima S, Ozawa Y, Yamaguchi S, Goda S, Kimura T, Kodama K, Matsuki M, Miyano SW, Yokoi A, Kato Y, Funahashi Y. Adachi Y, et al. Among authors: yokoi a. Cancer Res. 2022 Jan 15;82(2):292-306. doi: 10.1158/0008-5472.CAN-20-2426. Epub 2021 Nov 9. Cancer Res. 2022. PMID: 34753772
Harlequin Syndrome.
Yamaguchi H, Yokoi A, Kamimura K, Ishida Y, Toyoshima D, Maruyama A. Yamaguchi H, et al. Among authors: yokoi a. Indian J Pediatr. 2018 Aug;85(8):700-701. doi: 10.1007/s12098-017-2557-0. Epub 2017 Dec 14. Indian J Pediatr. 2018. PMID: 29238939 No abstract available.
Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma.
Knutson SK, Kawano S, Minoshima Y, Warholic NM, Huang KC, Xiao Y, Kadowaki T, Uesugi M, Kuznetsov G, Kumar N, Wigle TJ, Klaus CR, Allain CJ, Raimondi A, Waters NJ, Smith JJ, Porter-Scott M, Chesworth R, Moyer MP, Copeland RA, Richon VM, Uenaka T, Pollock RM, Kuntz KW, Yokoi A, Keilhack H. Knutson SK, et al. Among authors: yokoi a. Mol Cancer Ther. 2014 Apr;13(4):842-54. doi: 10.1158/1535-7163.MCT-13-0773. Epub 2014 Feb 21. Mol Cancer Ther. 2014. PMID: 24563539
An update in the management of pediatric sarcoma.
Sandler G, Yokoi A, Hayes-Jordan A. Sandler G, et al. Among authors: yokoi a. Curr Opin Pediatr. 2019 Jun;31(3):368-377. doi: 10.1097/MOP.0000000000000767. Curr Opin Pediatr. 2019. PMID: 31090579 Review.
The effect of instruction on motor skill learning.
Popp NJ, Yokoi A, Gribble PL, Diedrichsen J. Popp NJ, et al. Among authors: yokoi a. J Neurophysiol. 2020 Nov 1;124(5):1449-1457. doi: 10.1152/jn.00271.2020. Epub 2020 Sep 30. J Neurophysiol. 2020. PMID: 32997556 Free article.
ChrXq27.3 miRNA cluster functions in cancer development.
Yoshida K, Yokoi A, Yamamoto Y, Kajiyama H. Yoshida K, et al. Among authors: yokoi a. J Exp Clin Cancer Res. 2021 Mar 25;40(1):112. doi: 10.1186/s13046-021-01910-0. J Exp Clin Cancer Res. 2021. PMID: 33766100 Free PMC article. Review.
232 results